2023 Highlights in Friedreich's Ataxia: A Review of New Data

This activity is intended for neurologists, pediatricians, primary care physicians, and other clinicians who treat patients with FRDA.

The goal of this activity is for learners to be better able to summarize data released in 2023 on the diagnosis and treatment of FRDA.

Upon completion of this activity, participants will: